Endocrine therapy leads the first- and second-line treatment options for hormone receptor-positive advanced breast cancer—comments on the Monarch plus study
@article{TBCR60626, author = {Xiaojia Wang}, title = {Endocrine therapy leads the first- and second-line treatment options for hormone receptor-positive advanced breast cancer—comments on the Monarch plus study}, journal = {Translational Breast Cancer Research}, volume = {3}, number = {0}, year = {2022}, keywords = {}, abstract = {}, issn = {2218-6778}, url = {https://tbcr.amegroups.org/article/view/60626} }